Onco-Metabolism Research Inhibitor: 5-Amino-1MQ and the Warburg Effect

1. Introduction: Nicotinamide N-Methyltransferase (NNMT) and Cancer Metabolism

Cancer cells exhibit distinctive metabolic reprogramming, a hallmark often referred to as the Warburg effect, characterized by an increased dependence on glycolysis even in the presence of oxygen. While much research focuses on key glycolytic enzymes, emerging evidence highlights the crucial role of peripheral metabolic enzymes in supporting and driving oncogenesis. Nicotinamide N-Methyltransferase (NNMT) is one such enzyme that has garnered significant attention due to its frequent overexpression in numerous aggressive cancers, including gastric, ovarian, and renal carcinomas.

This document serves as the scientific background and usage guide for the Onco-Metabolism Research Inhibitor, 5-Amino-1MQ, a compound specifically designed to investigate the metabolic and epigenetic consequences of NNMT inhibition in tumor models.

2. Scientific Background: NNMT's Dual Role in Onco-Metabolism and Epigenetics

NNMT acts at the intersection of cellular energy metabolism and epigenetic regulation, making it a powerful therapeutic target for reversing the malignant phenotype. The overexpression of NNMT in cancer is not merely an incidental finding; it fundamentally alters the cellular environment in ways that promote proliferation and survival.

2.1. The Epigenetic Link: NNMT as a SAM Consumer

NNMT consumes S-adenosylmethionine (SAM) as a cofactor to catalyze the methylation of nicotinamide (NAM) to 1-methylnicotinamide (1-MNA). This process is critical because SAM is the universal methyl donor for virtually all cellular methylation reactions, most notably those involved in epigenetic regulation.

Key Epigenetic Consequences of NNMT Overexpression:

• Depletion of SAM: High levels of NNMT rapidly deplete the cellular pool of SAM.
• Altered Methylation Landscape: The reduction in available SAM leads to a global alteration in methylation states. Specifically, this results in:
• Hypomethylation of Histones: Changes in histone methylation patterns (e.g., H3K4me3, H3K27me3) can lead to the inappropriate activation of oncogenes or silencing of tumor suppressor genes.
• Hypomethylation of DNA: DNA hypomethylation, particularly at gene-rich areas, is a common feature of cancer and contributes to genomic instability and aberrant gene expression.

5-Amino-1MQ, by inhibiting NNMT, is hypothesized to restore proper SAM levels, thereby rescuing and normalizing the methylation patterns of both histones and DNA in tumor cells.

File

2.2. Metabolic Reprogramming and the "Metabolic Sink"

Beyond its epigenetic role, NNMT overexpression creates a "metabolic sink." By consuming NAM and SAM, NNMT diverts these critical metabolites away from other essential pathways.

The Sponge Effect: Cancer cells with high NNMT exhibit a "methyl sink" phenotype. They sponge up and rapidly utilize SAM, preventing it from being used in other anti-proliferative or regulatory processes. This metabolic diversion supports the high energetic and biosynthetic demands of rapid cell division.

Therapeutic Goal: Investigating the inhibition of cancer cell proliferation and migration by depriving them of this "metabolic sink" they use to survive. By reversing the "methyl sink" phenotype, 5-Amino-1MQ aims to disrupt the supportive metabolic environment of the tumor cell.

3. The Inhibitor: 5-Amino-1MQ

5-Amino-1MQ is a potent and selective small-molecule inhibitor of NNMT. It is designed specifically for research use to probe the biological functions of NNMT in cancer cell models.

3.1. Mechanism of Action

5-Amino-1MQ acts as an active-site inhibitor, competing with the endogenous substrate, nicotinamide, or acting as an uncompetitive inhibitor with respect to SAM. Its activity is characterized by:

• High Potency: Achieves significant NNMT inhibition at low micromolar concentrations.
• Selectivity: Exhibits high selectivity for NNMT, minimizing off-target effects that could complicate interpretation of research results.

3.2. Pharmacological Profile (In Vitro)

Parameter

Value

Notes

Target

Nicotinamide N-Methyltransferase (NNMT)

Highly selective

Mode of Action

Enzyme Inhibitor

Inhibits methylation of NAM

Cell Line Suitability

Gastric, Ovarian, Renal, others

Applicable to any cancer cell overexpressing NNMT

Optimal Concentration Range

1 to 50 µM

Dependent on cell line and assay endpoint

Half-life (in culture media)

Date

Stable for short-term (24-72h) studies

4. Usage and Experimental Protocols

The Onco-Metabolism Research Inhibitor (5-Amino-1MQ) is intended exclusively for in vitro tumor cell line studies. The following sections outline general usage guidelines and suggested experimental designs.

4.1. Preparation and Storage

Storage: Store the powder at -20°C, protected from light and moisture.

Reconstitution:

1. Allow the vial to reach room temperature before opening.
2. For a standard stock concentration of 10 mM, dissolve File mg of 5-Amino-1MQ in 100% DMSO.
3. Vortex until completely dissolved.
4. Aliquot the stock solution into small volumes and store at -20°C. Avoid freeze-thaw cycles.
5. Working Concentration: Dilute the stock solution immediately before use into cell culture media. The final concentration of DMSO in the cell culture must not exceed 0.1% (v/v) to minimize vehicle toxicity.

4.2. Recommended Cell Lines

Research should prioritize cell lines known to exhibit high endogenous NNMT expression, as these are most sensitive to the inhibitor's effects.

Cancer Type

Example Cell Line

Rationale

Gastric

AGS, MKN-45

Often high NNMT expression

Ovarian

SKOV3, A2780

Frequent NNMT overexpression

Renal Clear Cell

ACHN, 786-O

Identified as a key metabolic driver

Hepatocellular

HepG2

NNMT linked to metabolic shift

4.3. Suggested Experimental Endpoints (Page 5)

Focus Area

Assay/Method

Expected Outcome of NNMT Inhibition

Proliferation

MTT/XTT assay, Cell counting

Decreased cell viability and growth

Migration/Invasion

Wound healing assay, Transwell assay

Reduced migratory and invasive potential

Epigenetics

Western blot for H3K4/27/9 methylation, LC-MS/MS for global SAM:SAH ratio

Restoration of methylation marks, Increased SAM:SAH ratio

Metabolism

Seahorse XF analysis (OCR/ECAR), Glucose uptake assay

Shift away from Warburg metabolism (decreased glycolysis)

Gene Expression

qRT-PCR, RNA-Seq

Reversal of NNMT-driven gene signatures

5. Detailed Epigenetic Analysis Protocol

The primary focus of 5-Amino-1MQ is to reverse NNMT-driven epigenetic changes. This section provides a detailed protocol for assessing global methylation status.

5.1. Assessing Global SAM:SAH Ratio

The ratio of S-adenosylmethionine (SAM) to S-adenosylhomocysteine (SAH) is the most critical metric for cellular methylation potential.

Procedure:

1. Seed NNMT-overexpressing cells (e.g., ACHN or SKOV3) at 50-70% confluence.
2. Treat with varying concentrations of 5-Amino-1MQ (e.g., 5 µM, 10 µM, 20 µM) for 24, 48, or 72 hours. Include a vehicle control (0.1% DMSO).
3. Harvest cells and perform metabolite extraction using a standard cold methanol or perchloric acid protocol.
4. Analyze SAM and SAH levels using Liquid Chromatography-Mass Spectrometry/Mass Spectrometry (LC-MS/MS).
5. Data Interpretation: An effective reversal of the methyl sink is indicated by a significant increase in the cellular SAM concentration and an elevated SAM:SAH ratio in the 5-Amino-1MQ treated groups compared to the vehicle control.

5.2. Histone Methylation Analysis

NNMT inhibition is expected to restore histone methylation patterns.

Procedure:

1. Treat cells as described in 5.1.
2. Harvest cells and isolate total protein or, preferably, acid-extract histones using a commercial kit.
3. Perform Western Blot analysis using specific antibodies targeting critical histone methylation marks, such as:

• H3K4me3 (often decreased in NNMT-high cancers)
• H3K27me3 (often decreased/increased depending on cancer type)
• H3K9me3 (heterochromatin mark)

1. Data Interpretation: Bands showing increased intensity for previously reduced methylation marks indicate the restoration of methylation activity following NNMT inhibition.

6. Detailed Onco-Metabolism Analysis Protocol (Page 7)

Investigating how 5-Amino-1MQ affects the Warburg phenotype is crucial. The Seahorse XF Analyzer is the gold standard for real-time metabolic flux analysis.

6.1. Metabolic Flux Analysis (Seahorse XF)

This assay measures the Oxygen Consumption Rate (OCR) for mitochondrial respiration and the Extracellular Acidification Rate (ECAR) for glycolysis.

Procedure:

1. Seed cells in a specialized Seahorse XF culture plate one day prior to the assay.
2. Treat the cells overnight (16-24 hours) with the optimal inhibitory concentration of 5-Amino-1MQ (determined via dose-response).
3. Perform the standard Mito Stress Test to measure OCR and the Glycolysis Stress Test to measure ECAR.
4. Mito Stress Test Drugs (Injections): Oligomycin, FCCP, Rotenone/Antimycin A.
5. Glycolysis Stress Test Drugs (Injections): Glucose, Oligomycin, 2-DG.
6. Data Interpretation:

• Mitochondrial Function: Changes in basal respiration, maximal respiration, and spare respiratory capacity.
• Glycolysis: A decrease in Basal ECAR and Glycolytic Capacity in the 5-Amino-1MQ treated cells would suggest a shift away from the Warburg effect and reduced glycolytic dependency.

6.2. Glucose Uptake Assay

A decrease in glucose uptake is a direct measure of reduced glycolytic activity.

Procedure:

1. Treat cells with 5-Amino-1MQ for 48 hours.
2. Wash cells and incubate with a fluorescently labeled glucose analog (e.g., 2-NBDG).
3. Measure the intracellular fluorescence intensity using a plate reader or flow cytometry.
4. Data Interpretation: Lower fluorescence intensity in the 5-Amino-1MQ group compared to the control indicates reduced glucose uptake.

7. Analyzing Proliferation and Migration

The functional output of NNMT inhibition should be a reduction in tumor growth characteristics.

7.1. Cell Viability and Proliferation (MTT/XTT Assay)

These assays measure metabolic activity, which correlates strongly with viable cell number.

Procedure:

1. Seed cells in a 96-well plate.
2. Treat with a dose-response range of 5-Amino-1MQ (e.g., 0.1 µM to 100 µM) for 72 hours.
3. Add the MTT or XTT reagent and incubate according to the manufacturer's instructions.
4. Measure absorbance with a plate reader.
5. Data Interpretation: Calculate the IC50 value, representing the concentration needed for 50% growth inhibition.

7.2. Cell Migration (Wound Healing Assay)

Procedure:

1. Seed cells in a 6-well plate until a confluent monolayer is formed.
2. Use a sterile pipette tip to scratch a line down the center of the well (the "wound").
3. Wash cells to remove debris, and replace media containing the optimal concentration of 5-Amino-1MQ or vehicle control.
4. Take images of the same fields immediately (0 hours) and at subsequent time points (e.g., 12, 24, 48 hours).
5. Data Interpretation: Measure the residual wound area at each time point. Reduced migration in the 5-Amino-1MQ group compared to the control demonstrates functional inhibition of the metastatic potential.

8. Safety and Handling (Page 9)

5-Amino-1MQ is a research-use-only compound. Standard laboratory safety practices must be followed.

8.1. General Handling Guidelines

• Wear appropriate Personal Protective Equipment (PPE), including a lab coat, gloves, and eye protection.
• Handle the compound in a chemical fume hood when weighing or preparing stock solutions.
• Dispose of all solutions and contaminated materials in accordance with institutional hazardous waste protocols.

8.2. Troubleshooting Common Issues

Problem

Possible Cause

Solution

Low Cell Viability in Control

High DMSO concentration in media

Ensure final DMSO concentration is ≤ 0.1%

No Effect from 5-Amino-1MQ

Low NNMT expression in chosen cell line

Confirm NNMT expression via Western blot or use a validated high-expression line

Inconsistent Methylation Data

Poor quality or low yield of SAM/Histone extraction

Optimize extraction protocol; ensure cells are harvested at consistent confluence

9. Conclusion and Future Directions

The Onco-Metabolism Research Inhibitor, 5-Amino-1MQ, provides researchers with a critical tool to dissect the complex interplay between metabolism (the Warburg effect) and epigenetics in aggressive cancers. By specifically targeting NNMT and reversing the deleterious "methyl sink," this compound allows for the detailed investigation of how restoration of proper cellular methylation patterns can lead to inhibition of proliferation, migration, and the reversal of the malignant phenotype.

Further research utilizing 5-Amino-1MQ should focus on:

• Investigating synergistic effects with standard-of-care chemotherapeutics.
• Identifying novel downstream transcriptional targets whose methylation status is restored by NNMT inhibition.
• Using in vitro models to confirm the compound's effect on cancer stem cell populations.

For technical support or to report unusual findings, please contact Person at the Research Support Center, located at Place.

Reference Material: A comprehensive bibliography and Material Safety Data Sheet (MSDS) are available in the supplementary file: File. We recommend scheduling a consultation with our scientific team before commencing large-scale studies. Schedule a consultation here: Calendar event.